Abstract
Susceptibility to hepatitis B infection appears to be in part genetically determined. The HLA specificity Bw35 is commonly associated with a higher frequency of both transient and persistent hepatitis B surface antigen in the serum. Persistent hepatitis B surface antigenemia occurring in patients with end stage renal disease while on dialysis is associated with a poor prognosis and markedly decreased survival regardless of whether the individual is treated subsequently by chronic dialysis or by transplantation. We conclude that persistent hepatitis B surface antigenemia is not a contraindication to transplantation since outcome is not improved by management on hemodialysis.
Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blumberg B. S., Friedlaender J. S., Woodside A., Sutnick A. I., London W. T. Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A. 1969 Apr;62(4):1108–1115. doi: 10.1073/pnas.62.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hillis W. D., Hillis A., Bias W. B., Walker W. G. Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med. 1977 Jun 9;296(23):1310–1314. doi: 10.1056/NEJM197706092962302. [DOI] [PubMed] [Google Scholar]
- Hillis W. D., Hillis A., Walker W. G. Hepatitis B surface antigenemia in renal transplant recipients. Increased mortality risk. JAMA. 1979 Jul 27;242(4):329–332. [PubMed] [Google Scholar]
- Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
- Patterson M. J., Hourani M. R., Mayor G. H. HLA antigens and hepatitis B virus. N Engl J Med. 1977 Nov 17;297(20):1124–1124. doi: 10.1056/NEJM197711172972014. [DOI] [PubMed] [Google Scholar]
- Pirson Y., Alexandre G. P., Ypersele C. Long-term effect of hbs antigenemia on patient survival after renal transplantation. N Engl J Med. 1977 Jan 27;296(4):194–196. doi: 10.1056/NEJM197701272960404. [DOI] [PubMed] [Google Scholar]
- Szmuness W., Prince A. M., Grady G. F., Mann M. K., Levine R. W., Friedman E. A., Jacobs M. J., Josephson A., Ribot S., Shapiro F. L. Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA. 1974 Feb 25;227(8):901–906. doi: 10.1001/jama.227.8.901. [DOI] [PubMed] [Google Scholar]
- Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]